house · trading 2023-05-24 → 2024-07-05
*Notional-weighted price return on disclosed buys from the last ~3 years, marked to the latest close — open positions, per-share (share counts aren't disclosed, so this is price performance, not realized $ P&L).
By recent-buy return, Laurel Mrs Lee ranks #120 of 122 lawmakers — in the bottom 98%.
▮ buys · ▮ sells
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2024-07-05 | AAPL | SELL | $15K–$50K | $226.34 | $314.58 2026-08-27 | -39.0% exit |
| 2024-07-05 | AAPL | BUY | $15K–$50K | $226.34 | $314.58 2026-08-27 | +39.0% |
| 2024-05-06 | HURA | BUY | $100K–$250K | $5.08 | $2.13 2026-08-27 | -58.0% |
| 2023-12-29 | BABA | SELL | $100K–$250K | $77.51 | $116.31 2026-08-27 | -50.1% exit |
| 2023-05-24 | GSK | BUY | $1K–$15K | $34.69 | $50.27 2026-08-27 | +44.9% |
| 2023-05-24 | GOLD | BUY | $1K–$15K | $36.10 | $45.98 2026-08-27 | +27.4% |
Return: buys are marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (how the stock moved after the sale, seller's perspective).
| Member | Shared tickers |
|---|---|
| Thomas H Tuberville | 4 · BABA, AAPL, GOLD, GSK |
| James B. Renacci | 3 · BABA, AAPL, GSK |
| Thomas R Carper | 3 · AAPL, GOLD, GSK |
| Sheldon Whitehouse | 3 · BABA, AAPL, GOLD |
| Pat Roberts | 3 · BABA, AAPL, GOLD |
| Kurt Schrader | 3 · BABA, AAPL, GSK |
| Kenny Marchant | 3 · BABA, AAPL, GSK |
| Pete Sessions | 3 · BABA, AAPL, GSK |
| Roger W. Marshall | 3 · BABA, AAPL, GSK |
| Laurel Lee | 3 · BABA, HURA, AAPL |
| Alan S. Lowenthal | 2 · BABA, AAPL |
| Josh Gottheimer | 2 · BABA, AAPL |